News

The partnership, which has received £118 million (US$158 million) in research funding, aims to establish a better ...
Aficamten beat metoprolol for oHCM, EMA/WHO hit 10 yrs, Oxford and EIT collaborated on AI vaccine, Offit's FDA exit stirred ...
The nonprofit is calling upon its community of experts in both artificial intelligence and machine learning to continue ...
Paul Offit removed from FDA vaccine panel as RFK Jr. reshapes US immunization policy, raising concerns for bio/pharma and ...
The agency says it will now publish complete response letters promptly, offering developers early insight into regulatory deficiencies to improve development planning.
Aficamten is a small-molecule cardiac myosin inhibitor that was compared for the first time in the trial to the ...
Pharma manufacturers must securely destroy expired or off-spec drugs to meet DEA standards, avoid compliance risks, and ...
This article previews some formulation topics discussed in the Pharma Fundamentals series, which aims to enhance learning for professionals in pharmaceutical drug development and manufacturing.
The laboratory services provider is responding to growing demand for packaging and microbiological testing by expanding its ...
Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...
Cereno reports that its lead program, CS1, demonstrated encouraging efficacy while meeting its primary endpoint of safety and ...
To find out how FDA’s new draft guidance, Oncology Therapeutic Radiopharmaceuticals: Dosage Optimization During Clinical ...